Enhancing myocardial salvage and regeneration as adjuncts to reperfusion therapy: unresolved issues after myocardial infarction
- PMID: 19324434
- DOI: 10.1016/j.ijcard.2009.03.030
Enhancing myocardial salvage and regeneration as adjuncts to reperfusion therapy: unresolved issues after myocardial infarction
Abstract
Despite substantial advances in the treatment of acute myocardial infarction, ischemic cardiac injury and ventricular dysfunction may develop in patients undergoing reperfusion therapy. In the past few years, several experimental and clinical studies have investigated ways of enhancing myocardial salvage and regeneration. Although clinical evidence suggests that some treatment strategies might be able to enhance myocardial salvage and regeneration, many open questions remain, including the exact mechanisms leading to benefits, the influence of patient characteristics, optimal clinical indication and patient selection, and delivery method, route, and timing of therapies. Further clinical trials are needed to clarify these issues.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.
Comment on
-
Timing of granulocyte-colony stimulating factor treatment after acute myocardial infarction and recovery of left ventricular function: results from the STEMMI trial.Int J Cardiol. 2010 Apr 30;140(3):351-5. doi: 10.1016/j.ijcard.2008.11.120. Epub 2009 Jan 7. Int J Cardiol. 2010. PMID: 19131132 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
